Vertex Pharmaceuticals reported $1.57B in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 110.02M 8.15M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Alnylam Pharmaceuticals ALNY:US $ 190.3M 35.75M
Amgen AMGN:US $ 4889M 478M
Biogen BIIB:US $ 2315.3M 99.4M
Biomarin Pharmaceutical BMRN:US $ 374.63M 8.77M
Bluebird Bio BLUE:US $ -7829000 18.34M
Bristol Myers Squibb BMY:US $ 9252M 682M
Gilead Sciences GILD:US $ 4827M 235M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Insmed INSM:US $ 34.53M 4.16M
Intercept Pharmaceuticals ICPT:US $ 95.96M 15.11M
Johnson & Johnson JNJ:US $ 15725M 440M
Merk MRK:US $ 8718M 93M
Moderna Inc MRNA:US 3.6B 1.86B
Neurocrine Biosciences NBIX:US $ 285.8M 52.1M
Novartis NOVN:VX 9.54B 679M
Pfizer PFE:US $ 11985M 1575M
Ptc Therapeutics PTCT:US $ 109.32M 0.48M
Puma Biotechnology PBYI:US $ 41.42M 27.2M
Regeneron Pharmaceuticals REGN:US $ 4444.8M 2224.1M
Sarepta Therapeutics SRPT:US $ 144.57M 19.99M
Seattle Genetics SGEN:US $ 310.39M 42.54M
Ultragenyx Pharmaceutical RARE:US $ 83.84M 10.37M
United Therapeutics UTHR:US $ 409.3M 53.2M
Vertex Pharmaceuticals VRTX:US $ 1565.4M 33.42M
YTE INCY:US $ 673.08M 92.18M